Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Non-invasive monitoring of lymphocyte response to glucocorticoid-induced TNF receptor-related protein agonism with an anti-CD3ε PET probe

Oluwatayo Ikotun, Jodi Moriguchi, Stephanie Matyas, Brittany Yerby, Opas Nuanmanee, Pedro Beltran, Gordon Moody and Charles Glaus
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 420;
Oluwatayo Ikotun
4Research Imaging Sciences Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jodi Moriguchi
3Oncology Research Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Matyas
2Clinical Immunology Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Yerby
4Research Imaging Sciences Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Opas Nuanmanee
1Biologic Optimization Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Beltran
3Oncology Research Amgen Inc. Thousand Oaks CA United States
4Research Imaging Sciences Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Moody
3Oncology Research Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Glaus
4Research Imaging Sciences Amgen Inc. Thousand Oaks CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 420

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Oluwatayo Ikotun4,
  2. Jodi Moriguchi3,
  3. Stephanie Matyas2,
  4. Brittany Yerby4,
  5. Opas Nuanmanee1,
  6. Pedro Beltran3,4,
  7. Gordon Moody3 and
  8. Charles Glaus4
  1. 1Biologic Optimization Amgen Inc. Thousand Oaks CA United States
  2. 2Clinical Immunology Amgen Inc. Thousand Oaks CA United States
  3. 3Oncology Research Amgen Inc. Thousand Oaks CA United States
  4. 4Research Imaging Sciences Amgen Inc. Thousand Oaks CA United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016700
Jun 20162800
Jul 20161000
Aug 2016400
Sep 2016800
Oct 2016700
Nov 2016900
Dec 2016900
Jan 2017700
Feb 20171400
Mar 20171000
Apr 20171000
May 20171100
Jun 20171200
Jul 2017300
Aug 2017200
Sep 2017200
Oct 2017300
Nov 2017400
Dec 2017300
Jan 2018100
Feb 2018100
Mar 2018300
Apr 2018600
May 2018200
Jun 20181500
Aug 2018400
Sep 2018300
Nov 2018500
Jan 2019200
Mar 2019100
Apr 2019500
May 2019300
Jun 2019100
Jul 2019100
Aug 2019100
Sep 2019100
Jan 2020100
Feb 2020900
Mar 20201400
Apr 2020900
May 2020100
Jun 2020100
Jul 2020300
Aug 20201400
Sep 20203000
Oct 20201000
Nov 20201600
Dec 2020800
Jan 2021400
Feb 2021800
Mar 2021700
Apr 2021800
May 20212200
Jun 20211400
Jul 202114100
Aug 20217500
Sep 20211500
Oct 20211300
Nov 20216300
Dec 20213500
Jan 20227200
Feb 20222200
Mar 20221400
Apr 20221200
May 20222500
Jun 2022100
Aug 2022300
Sep 2022200
Oct 2022100
Nov 2022100
Dec 2022400
Jan 2023700
Feb 2023200
Mar 2023300
Apr 20231300
May 2023100
Jun 2023200
Jul 2023200
Aug 2023200
Sep 2023500
Oct 2023500
Nov 2023300
Dec 2023200
Jan 2024600
Feb 2024300
Mar 2024400
Apr 2024800
May 2024500
Jun 2024300
Aug 20241400
Sep 20241600
Oct 2024200
Nov 2024400
Dec 2024100
Jan 2025200
Feb 2025500
Mar 2025400
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Non-invasive monitoring of lymphocyte response to glucocorticoid-induced TNF receptor-related protein agonism with an anti-CD3ε PET probe
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Non-invasive monitoring of lymphocyte response to glucocorticoid-induced TNF receptor-related protein agonism with an anti-CD3ε PET probe
Oluwatayo Ikotun, Jodi Moriguchi, Stephanie Matyas, Brittany Yerby, Opas Nuanmanee, Pedro Beltran, Gordon Moody, Charles Glaus
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 420;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Non-invasive monitoring of lymphocyte response to glucocorticoid-induced TNF receptor-related protein agonism with an anti-CD3ε PET probe
Oluwatayo Ikotun, Jodi Moriguchi, Stephanie Matyas, Brittany Yerby, Opas Nuanmanee, Pedro Beltran, Gordon Moody, Charles Glaus
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 420;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Imaging Tumor Response to Therapy

  • Use of paired FDG and 18F-Fluoride PET to predict response to therapy in patients with bone dominant metastases from breast cancer
  • In vitro and in vivo imaging of irradiation induced changes in PARP1 expression in oral cancer cell lines
Show more Imaging Tumor Response to Therapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire